IDiyas

For the Inventor, By the Inventor

Braunschweig, Germany

Peter Wagner

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Braunschweig, DE (2010 - 2016)
  • Neusäss/Westheim, DE (2016)
  • Denkte, DE (2016 - 2019)

Company Filing History:

goldMedal8 out of 16,338 
 
E.i. Dupont De Nemours and Company
 patents
silverMedal4 out of 28 
 
Ra Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 35 
 
Tripep Ab
 patents
4. 1 out of 162 
 
Sanofi Pasteur Inc.
 patents
5. 2 out of 832,680 
Other
 patents

Years Active: 2010-2019

Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 10272132 - Peptide and peptidomimetic inhibitors (2019-04-30),
2. 9999650 - Peptide and peptidomimetic inhibitors (2018-06-19),
3. 9644004 - Peptide and peptidomimetic inhibitors (2017-05-09),
4. 9289067 - Piece of seating furniture (2016-03-22),
5. 9284548 - High affinity adaptor molecules for redirecting antibody specifity (2016-03-15),
6. 9238676 - Peptide and peptidomimetic inhibitors (2016-01-19),
7. 9145445 - Methods for purifying pertussis toxin and peptides useful therefor (2015-09-29),
8. 8455614 - PMMA binding peptides (2013-06-04),
9. 8404214 - PMMA binding peptides (2013-03-26),
10. 8389675 - PMMA binding peptides (2013-03-05),
11. 8378065 - PMMA binding peptides (2013-02-19),
12. 8299210 - Methods for purifying pertussis toxin and peptides useful therefor (2012-10-30),
13. 8287845 - Hair-binding peptides (2012-10-16),
14. 8263737 - PMMA binding peptides (2012-09-11),
15. 8206693 - PMMA binding peptides (2012-06-26),

Title: The Innovative Contributions of Peter Wagner: A Prominent Inventor from Braunschweig

Introduction: Peter Wagner, based in Braunschweig, Germany, is a highly regarded inventor with a prolific portfolio of 16 patents. His work primarily focuses on the development of peptide and peptidomimetic inhibitors, showcasing significant advancements in therapeutic methods.

Latest Patents: Among his latest inventions, Peter has developed inhibitors and/or antagonists of plasma kallikrein. This invention not only highlights his expertise in biochemistry but also emphasizes the potential therapeutic applications that these inhibitors offer.

Career Highlights: Throughout his career, Peter has made substantial contributions while working for renowned companies such as E.I. Dupont De Nemours and Company and Ra Pharmaceuticals, Inc. His innovative spirit and commitment to researching novel methods have cemented his reputation in the field of biotechnology.

Collaborations: Peter's journey in innovation has been enriched by collaborations with esteemed colleagues like Eberhard Schneider and Gregor Schurmann. These partnerships have propelled his research to new heights and fostered an environment of creativity and excellence.

Conclusion: With a remarkable array of patents and significant contributions to the field of biochemistry, Peter Wagner stands out as a leading inventor. His work continues to inspire future innovations and underscores the vital role of research in developing new therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…